[go: up one dir, main page]

ECSP19090645A - Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta - Google Patents

Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta

Info

Publication number
ECSP19090645A
ECSP19090645A ECSENADI201990645A ECDI201990645A ECSP19090645A EC SP19090645 A ECSP19090645 A EC SP19090645A EC SENADI201990645 A ECSENADI201990645 A EC SENADI201990645A EC DI201990645 A ECDI201990645 A EC DI201990645A EC SP19090645 A ECSP19090645 A EC SP19090645A
Authority
EC
Ecuador
Prior art keywords
composition
oligosaccharid
make
includes mannose
mannose
Prior art date
Application number
ECSENADI201990645A
Other languages
English (en)
Inventor
Christof Franz Küsters
Bruno Frédéri Stengel
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of ECSP19090645A publication Critical patent/ECSP19090645A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pediatric Medicine (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una composición que comprende manosa oligosacárido y un proceso para realizarla. La presente invención se refiere, además, a una composición que comprende manosa oligosacárido para uso en el tratamiento de humanos o animales.
ECSENADI201990645A 2017-06-14 2019-12-23 Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta ECSP19090645A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17175981 2017-06-14

Publications (1)

Publication Number Publication Date
ECSP19090645A true ECSP19090645A (es) 2020-01-31

Family

ID=59061903

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI201990645A ECSP19090645A (es) 2017-06-14 2019-12-23 Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta

Country Status (13)

Country Link
US (2) US11771124B2 (es)
EP (1) EP3638254A1 (es)
JP (2) JP2020527334A (es)
KR (1) KR102663532B1 (es)
CN (1) CN110753550A (es)
AU (2) AU2018284983B2 (es)
BR (1) BR112019026661A2 (es)
CA (1) CA3066727A1 (es)
CL (1) CL2019003670A1 (es)
EC (1) ECSP19090645A (es)
MX (1) MX384068B (es)
PH (1) PH12019550265B1 (es)
WO (1) WO2018232078A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230061329A1 (en) 2020-03-09 2023-03-02 Cargill, Incorporated Sweetener composition
WO2021183561A1 (en) 2020-03-09 2021-09-16 Cargill, Incorporated Sweetener composition
EP4117619A1 (en) * 2020-03-13 2023-01-18 Cargill, Incorporated Personal care composition comprising mannose oligosaccharides
US20230225350A1 (en) 2020-05-29 2023-07-20 Cargill, Incorporated Fat-based compositions
WO2021243151A1 (en) 2020-05-29 2021-12-02 Cargill, Incorporated Use of mannose oligosaccharide compositions for feeding crustaceans
BR112022024217A2 (pt) * 2020-05-29 2023-01-24 Cargill Inc Composição de oligossacarídeo de glicose, ração para animais ou produto de ração para animais de estimação, utilização da composição de oligossacáridos de glucose, e, processo para a fabricação de uma composição
CA3220437A1 (en) 2021-05-20 2022-11-24 Smile Makers, Llc Oral hygiene compositions and methods of use
CN117510655A (zh) * 2022-07-28 2024-02-06 保定冀中药业有限公司 一种用于抑制细菌生物被膜形成的聚甘露糖及其应用
WO2024242807A1 (en) 2023-05-25 2024-11-28 Cargill, Incorporated Co-dried fiber product comprising a core of insoluble fiber and an at least partial coating of soluble fiber

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0717685B2 (ja) * 1986-09-01 1995-03-01 台糖株式会社 縮合糖の製造方法
JPH089989A (ja) * 1994-07-04 1996-01-16 Meiji Milk Prod Co Ltd β−マンノシルオリゴ糖の製造方法
JP2001516388A (ja) * 1997-03-19 2001-09-25 カルター フード サイエンス インコーポレーテッド 低レベルの鉱酸を使用する単糖類及び二糖類の重合
JP2002262827A (ja) * 2001-03-13 2002-09-17 Ajinomoto General Foods Inc マンノオリゴ糖を含有する血清脂質改善組成物
JP3920073B2 (ja) * 2001-10-17 2007-05-30 昭和産業株式会社 新規α−１，２−マンノシダーゼ及び該酵素を用いたα−マンノシル糖化合物の製造法
JP2003231694A (ja) 2002-02-06 2003-08-19 Hokkaido Electric Power Co Inc:The 糖類重合体及びグリコシド類の製造方法
JP4259169B2 (ja) 2003-04-16 2009-04-30 昭和産業株式会社 新規α−１，２−マンノシダーゼおよびその遺伝子、ならびに該酵素を用いたα−マンノシル糖化合物の製造方法
JP4488852B2 (ja) 2004-09-17 2010-06-23 味の素ゼネラルフーヅ株式会社 体内脂肪低減作用を有する組成物
WO2007138047A2 (en) 2006-05-30 2007-12-06 Nutrition Sciences N.V./S.A. Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens
CN107674128B (zh) * 2010-01-28 2021-05-04 卡吉尔公司 用于制备缩聚物的微处理
EP2433970A1 (en) * 2010-09-28 2012-03-28 Cargill, Incorporated Microprocessing for preparing a polycondensate
WO2012061675A1 (en) * 2010-11-05 2012-05-10 Boston Therapeutics, Inc. Composition of purified soluble mannans for dietary supplements and methods of use thereof
JP4966429B1 (ja) 2011-01-07 2012-07-04 日本食品化工株式会社 糖縮合物並びにその製造方法および用途
JP2012158526A (ja) * 2011-01-31 2012-08-23 Niigata Institute Of Science & Technology Niigata Univ Of Pharmacy & Applied Life Sciences マンノオリゴ糖の製造法
JP5671594B2 (ja) 2012-11-28 2015-02-18 日本食品化工株式会社 糖縮合物の製造法
ES2989233T3 (es) 2014-04-14 2024-11-25 Biothera Inc Procedimiento de obtención de pared celular de levadura enriquecida con proteína de manano- oligosacárido
CN107427042A (zh) 2015-01-26 2017-12-01 卡德纳生物股份有限公司 用作食品成分的寡糖组合物和其制造方法
AU2016212026A1 (en) 2015-01-26 2017-08-31 Cadena Bio, Inc. Oligosaccharide compositions for use in nutritional compositions, and methods of producing thereof
JP6692629B2 (ja) * 2015-11-20 2020-05-13 国立大学法人静岡大学 ムチン分泌促進剤及びその利用
US20170173066A1 (en) 2015-12-22 2017-06-22 Purina Animal Nutrition Llc Method of feeding animals glucomannoprotein products

Also Published As

Publication number Publication date
JP2023071803A (ja) 2023-05-23
EP3638254A1 (en) 2020-04-22
MX2019015124A (es) 2020-02-17
PH12019550265B1 (en) 2024-03-01
CN110753550A (zh) 2020-02-04
PH12019550265A1 (en) 2021-01-11
KR102663532B1 (ko) 2024-05-08
MX384068B (es) 2025-03-14
AU2024227393A1 (en) 2024-11-07
AU2018284983A1 (en) 2020-01-30
KR20200019170A (ko) 2020-02-21
CA3066727A1 (en) 2018-12-20
RU2019144988A (ru) 2021-06-30
RU2019144988A3 (es) 2021-10-08
US11771124B2 (en) 2023-10-03
JP7607063B2 (ja) 2024-12-26
JP2020527334A (ja) 2020-09-10
US20200297019A1 (en) 2020-09-24
US20230413885A1 (en) 2023-12-28
AU2018284983B2 (en) 2024-07-25
BR112019026661A2 (pt) 2020-06-23
CL2019003670A1 (es) 2020-05-15
WO2018232078A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
ECSP19090645A (es) Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta
CO2019004003A2 (es) Composiciones y anticuerpos anti-lag-3
CO2019012353A2 (es) Formulaciones de anticuerpos anti-lag3 y coformulaciones de anticuerpos anti-lag3 y anticuerpos anti-pd-1
PE20180243A1 (es) Composiciones que comprenden cepas bacterianas
CO2018010458A2 (es) Composiciones y anticuerpos anti-tim-3
PE20180266A1 (es) Composiciones que comprenden cepas bacterianas
CU20200042A7 (es) Formulación liofilizada de un anticuerpo monoclonal contra la transtirretina
MX2018006240A (es) Composiciones que comprenden cepas bacterianas.
MX2018010680A (es) Composiciones que comprenden cepas bacterianas.
MX2018005315A (es) Composiciones y metodos para el tratamiento del cancer.
MX2018004515A (es) Agentes de anticuerpo especificos para cd19 humano y usos de los mismos.
MX383164B (es) Composicion que contiene arn para tratamiento de enfermedades tumorales.
BR112019017403A2 (pt) composições e métodos para o tratamento de câncer
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
AR096478A1 (es) Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos
MX395231B (es) Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos.
ECSP19057403A (es) Usos terapéuticos de un polvo de insectos
BR112018000776A2 (pt) métodos para tratamento de câncer usando apilimod
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
MX376323B (es) Recubrimiento anti-microbiano y metodo para formar el mismo.
CO2019014647A2 (es) Composiciones inmunogénicas
CO2017011778A2 (es) Un inhibidor de la actividad del csf-1r y composiciones farmaceuticas que lo comprenden
CO2018008249A2 (es) Composiciones terapéuticas y métodos para el tratamiento de la hepatitis b
MX2018001512A (es) Composiciones antimicrobianas que comprenden mupirocina y neomicina.
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.